Shuhong Wu
Chifeng University(CN)Chifeng Municipal Hospital(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer-related Molecular Pathways, RNA modifications and cancer, Chronic Lymphocytic Leukemia Research, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Design, Synthesis, Cytoselective Toxicity, Structure–Activity Relationships, and Pharmacophore of Thiazolidinone Derivatives Targeting Drug-Resistant Lung Cancer Cells(2008)177 cited
- → Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells(2015)147 cited
- → Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors(2005)125 cited
- → Selective Antitumor Activity of Ibrutinib in EGFR-Mutant Non–Small Cell Lung Cancer Cells(2014)101 cited
- → Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer(2014)90 cited
- → Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK(2004)89 cited